Home › Atherosclerosis › Alabama › Birmingham
Atherosclerosis clinical trials in Birmingham, AL
4 studies for Atherosclerosis are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Birmingham Clinical Research, Birmingham
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Birmingham
- Research Site, Birmingham
- Research Site, Irondale · 6 mi away
Pelacarsen Roll-over Extension Program
RecruitingPhase 3
- Parkway Medical Center, Birmingham
Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure
Recruiting
- University of Alabama at Birmingham, Birmingham
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Houston, TX10 studies
- Boston, MA10 studies
- Washington, DC9 studies
- Orlando, FL8 studies
- Hialeah, FL8 studies
- Arlington, VA8 studies
- Durham, NC7 studies
- Miami, FL7 studies
- Dallas, TX7 studies
- Las Vegas, NV7 studies
- Memphis, TN7 studies
- San Diego, CA6 studies
Other studies in Birmingham
- Cancer (all types)31 studies
- Breast Cancer24 studies
- Obesity23 studies
- Ovarian Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- Cardiovascular Disease17 studies
- COPD17 studies
- Overweight16 studies
- Cystic Fibrosis16 studies
- Endometrial Cancer16 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.